SomaLogic taps staff researcher to CTO role

BOULDER — SomaLogic Inc. has tapped Jason Cleveland, one of its lead researchers, as the company’s chief technology officer.

Cleveland will lead development of the company’s blood-analysis platform.

“His unique background is the balance between science, engineering and business that we need to bring proteomics to a much wider customer base,” SomaLogic Chief Operating Officer Melody Harris said in a statement.

SPONSORED CONTENT

Empowering communities

Rocky Mountain Health Plans (RMHP), part of the UnitedHealthcare family, has pledged its commitment to uplift these communities through substantial investments in organizations addressing the distinct needs of our communities.

The SomaScan platform reads thousands of proteins in a patient’s blood or urine sample that may signal illnesses or future health conditions and suggest potential treatments via machine learning analysis. SomaLogic raised $214 million in venture capital late last year to fund the test’s further commercialization to clinical drug companies.

Cleveland joined SomaLogic as a principal research fellow in 2018 and was a consultant to the company for three years prior. Prior to that, he was CEO of Lab79 Technologies Inc., a DNA-sequencing startup spun out from the University of Colorado Boulder.

© 2021 BizWest Media LLC